ALK POSITIVE
Clinical trials for ALK POSITIVE explained in plain language.
Never miss a new study
Get alerted when new ALK POSITIVE trials appear
Sign up with your email to follow new studies for ALK POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests drug combo to halt advanced cancer growth
Disease control OngoingThis early-stage study aims to find the safest and most effective dose of two oral medications, ceritinib and everolimus, when used together. It involves adults with advanced solid tumors or a specific type of lung cancer (ALK-positive non-small cell lung cancer) that has spread …
Matched conditions: ALK POSITIVE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
Targeted drug trial aims to stop lung Cancer's comeback
Disease control OngoingThis study is testing if a drug called crizotinib can help prevent early-stage lung cancer from coming back after surgery. It is for patients whose cancer has a specific genetic change called ALK-positive. After surgery, participants are randomly assigned to either take the drug …
Matched conditions: ALK POSITIVE
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC